Zobrazeno 1 - 10
of 50
pro vyhledávání: '"Shinichi, Fujioka"'
Autor:
Masanori Atsukawa, Akihito Tsubota, Chisa Kondo, Hidenori Toyoda, Makoto Nakamuta, Koichi Takaguchi, Tsunamasa Watanabe, Atsushi Hiraoka, Haruki Uojima, Toru Ishikawa, Motoh Iwasa, Toshifumi Tada, Akito Nozaki, Makoto Chuma, Shinya Fukunishi, Akira Asai, Toru Asano, Chikara Ogawa, Hiroshi Abe, Naoki Hotta, Toshihide Shima, Etsuko Iio, Shigeru Mikami, Yoshihiko Tachi, Shinichi Fujioka, Hironao Okubo, Noritomo Shimada, Joji Tani, Isao Hidaka, Akio Moriya, Kunihiko Tsuji, Takehiro Akahane, Naoki Yamashita, Tomomi Okubo, Taeang Arai, Kiyoshi Morita, Kazuhito Kawata, Yasuhito Tanaka, Takeshi Okanoue, Shin Maeda, Takashi Kumada, Katsuhiko Iwakiri, KTK49 Liver Study Group
Publikováno v:
Infectious Diseases and Therapy, Vol 9, Iss 4, Pp 851-866 (2020)
Abstract Introduction Clinical trials of direct-acting antivirals for patients with decompensated cirrhosis have been conducted, but there is limited information on the medicinal applications in clinical settings. We aimed to evaluate the safety and
Externí odkaz:
https://doaj.org/article/55849d97b2c94d3998b61e259f39e8f7
Autor:
Nao, Yamauchi, Takashi, Hongo, Manri, Kawakami, Kyosuke, Inoguchi, Syunsuke, Oguni, Noriya, Momoki, Akiko, Ueno, Fusao, Ikeda, Shinichi, Fujioka, Kazuhide, Yamamoto
Publikováno v:
Internal Medicine. 62:1365-1369
A 67-year-old man was admitted to our hospital with a high fever. Laboratory tests revealed leukopenia, thrombocytopenia, liver dysfunction, rhabdomyolysis, and hyperferritinemia. He was diagnosed with severe fever with thrombocytopenia syndrome (SFT
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fdc14e9426220ba88c4f4785a2495378
https://doi.org/10.2169/internalmedicine.9052-21
https://doi.org/10.2169/internalmedicine.9052-21
Autor:
Takashi Kumada, Hidenori Toyoda, Satoshi Yasuda, Takanori Ito, Kunihiko Tsuji, Shinichi Fujioka, Atsushi Hiraoka, Kazuya Kariyama, Kazuhiro Nouso, Toru Ishikawa, Tsutomu Tamai, Toshifumi Tada, Junko Tanaka
Publikováno v:
Journal of Viral Hepatitis. 29:919-929
The risk factors for hepatocellular carcinoma (HCC) development in patients whose duration of sustained virological response (SVR) is over 10 years are not fully understood. We compared the incidence of HCC development within and beyond 10 years afte
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2b175ebf4c7a9ac251e85d0683e5138b
https://doi.org/10.1111/jvh.13728
https://doi.org/10.1111/jvh.13728
Publikováno v:
Internal Medicine. 61:1151-1156
Pancreatic colloid carcinoma, also known as mucinous non-cystic carcinoma, is a rare subtype of pancreatic cancer accounting for 1%-3% of the pancreatic malignant neoplasms. We herein report a woman who initially presented for acute pancreatitis. Com
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::726b89e79d19b6646d238ac43960347c
https://doi.org/10.2169/internalmedicine.7345-21
https://doi.org/10.2169/internalmedicine.7345-21
Publikováno v:
Clinical Journal of Gastroenterology. 15:205-209
We report a rare case of neuroendocrine tumor of the ampulla of Vater in a 53-year-old Japanese male. The patient was admitted to our institution for workup of presyncope secondary to anemia. Medical history was pertinent for coronary artery disease,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7d85acf13ce0cb07d0e6395396056bae
https://doi.org/10.1007/s12328-021-01553-w
https://doi.org/10.1007/s12328-021-01553-w
Publikováno v:
Kansenshogaku Zasshi. 96:29-33
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f5eb4ad4789e06de5b964f8afad22b69
https://doi.org/10.11150/kansenshogakuzasshi.96.29
https://doi.org/10.11150/kansenshogakuzasshi.96.29
Autor:
Shigeru Mikami, Toshifumi Tada, Takashi Kumada, Shinichi Fujioka, Kazufumi Dohmen, Soo Ryang Kim, Tsutomu Tamai, Soo Ki Kim, Atsushi Hiraoka, Kunihiko Tsuji, Akemi Tsutsui, Kazuhiro Nouso, Hiroaki Okushin, Michitaka Imai, Ei Itobayashi, Toru Ishikawa, Yuto Watanabe, Kojiro Michitaka, Kazuya Kariyama, Hironori Tanaka, Joji Tani, Koichi Takaguchi, Masanori Atsukawa, Norio Itokawa, Hidenori Toyoda, Noritomo Shimada, Satoshi Yasuda, Hiroshi Shibata
Publikováno v:
Infectious Diseases and Therapy
Introduction The real-world virological efficacy and safety of interferon-free direct-acting antiviral (DAA) therapy with ledipasvir (LDV) plus sofosbuvir (SOF) were assessed in patients who were chronically infected with hepatitis C virus (HCV) geno
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7770088f855a103ff3f7fc2907a8df12
https://doi.org/10.1007/s40121-020-00364-9
https://doi.org/10.1007/s40121-020-00364-9
Autor:
Toshiki Ozato, Kazuhide Yamamoto, Junichiro Nasu, Masakuni Fujii, Shinichi Fujioka, Haruyuki Kawai, Junji Shiode, Masao Yoshioka, Sho Mizukawa
Publikováno v:
Clinical Journal of Gastroenterology. 13:1083-1090
Immune checkpoint inhibitor-related liver injury usually appears as a hepatitis pattern, with a cholangitis pattern being a rare immune-related adverse event. We report a Japanese man in his fifties with immune checkpoint inhibitor-induced cholangiti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::186d7b047992f325aa80f767e551c1c2
https://doi.org/10.1007/s12328-020-01218-0
https://doi.org/10.1007/s12328-020-01218-0
Autor:
Naoki Hotta, Toshihide Shima, Norio Itokawa, Akio Moriya, Katsuhiko Iwakiri, Takashi Kumada, Makoto Nakamuta, Chisa Kondo, Shin Maeda, Toru Ishikawa, Shigeru Mikami, Taeang Arai, Shinichi Fujioka, Atsushi Hiraoka, Shinya Fukunishi, Makoto Chuma, Yasuhito Tanaka, Hidenori Toyoda, Hironao Okubo, Haruki Uojima, Noritomo Shimada, Takeshi Okanoue, Takehiro Akahane, Takuya Genda, Joji Tani, Shintaro Ogawa, Koichi Takaguchi, Tsunamasa Watanabe, Masanori Atsukawa, Hiroshi Abe, Hiroki Ikeda, Chikara Ogawa, Akihito Tsubota, Asahiro Morishita, Toru Asano, Yoshihiko Tachi, Akito Nozaki, Tadashi Ikegami
Publikováno v:
Hepatology International. 14:225-238
Direct-acting anti-virals (DAAs) have markedly improved the effectiveness of anti-viral therapy for chronic hepatitis C (CHC) patients. In a phase III trial in Japan, treatment with the NS3/4A protease inhibitor glecaprevir and the NS5A inhibitor pib
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::37398fdeeaeb93023154fb7f4e4d5a96
https://doi.org/10.1007/s12072-020-10019-z
https://doi.org/10.1007/s12072-020-10019-z
Autor:
Hiroshi Matsushita, Kazuhiro Nouso, Hiroyuki Terasawa, Takuya Adachi, Soichiro Ako, Yasuto Takeuchi, Mari Mandai, Akinobu Takaki, Hideki Onishi, Hidenori Shiraha, Tetsushige Mimura, Hideaki Kinugasa, Nozomu Wada, Hiroyuki Okada, Fusao Ikeda, Shinichi Fujioka
Publikováno v:
Oncology. 98:311-317
Background: Mutations in the human telomerase reverse transcriptase (hTERT) gene promoter have been reported in hepatocellular carcinoma (HCC); however, analyses of these mutations in liquid biopsies have been technically difficult because of the hig
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::85983c427935a37e6fbc22417e4bddf4
https://doi.org/10.1159/000506135
https://doi.org/10.1159/000506135